1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
ARG 17 - LEU 18 OMEGA ANGLE = 147.581 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION IN MODEL 7
Bonvin, A.M.J.J.
Rullmann, J.A.C.
Lamerichs, R.M.J.N.
Boelens, R.
Kaptein, R.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Proteins
PSFGEY
0867
0887-3585
15
385
400
10.1002/prot.340150406
8460109
"Ensemble" iterative relaxation matrix approach: a new NMR refinement protocol applied to the solution structure of crambin.
1993
US
Proteins
PSFGEY
0867
0887-3585
15
385
"Ensemble" Iterative Relaxation Matrix Approach: A New NMR Refinement Protocol Applied to the Solution Structure of Crambin
1993
Springer-Verlag, Berlin
GW
COMPUTATION OF BIOMOLECULAR STRUCTURES; ACHIEVEMENTS PROBLEMS, AND PERSPECTIVES
2010
3540559515
1
Structure Determination by NMR-Application to Crambin
1992
GW
Thesis
2011
3540559515
2D NMR Studies of Biomolecules: Protein Structure and Protein-DNA Interactions
1989
IX
Eur.J.Biochem.
EJBCAI
0262
0014-2956
171
307
Secondary Structure and Hydrogen Bonding of Crambin in Solution
1988
NE
FEBS Lett.
FEBLAL
0165
0014-5793
219
426
1H NMR Characterization of Two Crambin Species
1987
1
2
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
4738.447
CRAMBIN
1
man
polymer
no
no
TTCCPSIVARSNFNVCRLPGTPEALCATYTGCIIIPGATCPGDYAN
TTCCPSIVARSNFNVCRLPGTPEALCATYTGCIIIPGATCPGDYAN
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Crambe
Crambe hispanica
subsp. abyssinica
sample
3721
Crambe hispanica subsp. abyssinica
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conf
struct_conf_type
repository
Initial release
Version format compliance
Version format compliance
Derived calculations
Other
1
0
1993-10-31
1
1
2008-03-24
1
2
2011-07-13
1
3
2017-11-29
_pdbx_database_status.process_site
Y
BNL
1993-04-14
REL
8
VAN GUNSTEREN,BERENDSEN
refinement
GROMOS
THR
1
n
1
THR
1
A
THR
2
n
2
THR
2
A
CYS
3
n
3
CYS
3
A
CYS
4
n
4
CYS
4
A
PRO
5
n
5
PRO
5
A
SER
6
n
6
SER
6
A
ILE
7
n
7
ILE
7
A
VAL
8
n
8
VAL
8
A
ALA
9
n
9
ALA
9
A
ARG
10
n
10
ARG
10
A
SER
11
n
11
SER
11
A
ASN
12
n
12
ASN
12
A
PHE
13
n
13
PHE
13
A
ASN
14
n
14
ASN
14
A
VAL
15
n
15
VAL
15
A
CYS
16
n
16
CYS
16
A
ARG
17
n
17
ARG
17
A
LEU
18
n
18
LEU
18
A
PRO
19
n
19
PRO
19
A
GLY
20
n
20
GLY
20
A
THR
21
n
21
THR
21
A
PRO
22
n
22
PRO
22
A
GLU
23
n
23
GLU
23
A
ALA
24
n
24
ALA
24
A
LEU
25
n
25
LEU
25
A
CYS
26
n
26
CYS
26
A
ALA
27
n
27
ALA
27
A
THR
28
n
28
THR
28
A
TYR
29
n
29
TYR
29
A
THR
30
n
30
THR
30
A
GLY
31
n
31
GLY
31
A
CYS
32
n
32
CYS
32
A
ILE
33
n
33
ILE
33
A
ILE
34
n
34
ILE
34
A
ILE
35
n
35
ILE
35
A
PRO
36
n
36
PRO
36
A
GLY
37
n
37
GLY
37
A
ALA
38
n
38
ALA
38
A
THR
39
n
39
THR
39
A
CYS
40
n
40
CYS
40
A
PRO
41
n
41
PRO
41
A
GLY
42
n
42
GLY
42
A
ASP
43
n
43
ASP
43
A
TYR
44
n
44
TYR
44
A
ALA
45
n
45
ALA
45
A
ASN
46
n
46
ASN
46
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
2
A
ARG
17
-12.82
7
A
A
ARG
LEU
17
18
147.58
1
A
ARG
10
0.152
SIDE CHAIN
1
A
TYR
29
0.071
SIDE CHAIN
2
A
ARG
17
0.114
SIDE CHAIN
3
A
TYR
29
0.081
SIDE CHAIN
4
A
TYR
29
0.100
SIDE CHAIN
6
A
TYR
44
0.068
SIDE CHAIN
7
A
TYR
29
0.076
SIDE CHAIN
1
8.93
1.40
112.40
121.33
A
A
A
CA
CB
CG2
THR
THR
THR
1
1
1
N
1
18.05
1.90
111.00
129.05
A
A
A
CA
CB
CG1
ILE
ILE
ILE
7
7
7
N
1
-5.05
0.70
120.80
115.75
A
A
A
CB
CG
CD2
PHE
PHE
PHE
13
13
13
N
1
20.31
2.00
110.40
130.71
A
A
A
CB
CA
C
ARG
ARG
ARG
17
17
17
N
1
-6.29
0.60
121.00
114.71
A
A
A
CB
CG
CD2
TYR
TYR
TYR
29
29
29
N
1
-5.39
0.60
121.00
115.61
A
A
A
CB
CG
CD1
TYR
TYR
TYR
44
44
44
N
2
9.34
1.40
112.40
121.74
A
A
A
CA
CB
CG2
THR
THR
THR
1
1
1
N
2
-5.76
0.70
120.80
115.04
A
A
A
CB
CG
CD2
PHE
PHE
PHE
13
13
13
N
2
17.47
2.00
110.40
127.87
A
A
A
CB
CA
C
ARG
ARG
ARG
17
17
17
N
2
-11.01
1.80
110.60
99.59
A
A
A
N
CA
CB
ARG
ARG
ARG
17
17
17
N
2
4.94
0.50
120.30
125.24
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
17
17
17
N
2
-3.90
0.50
120.30
116.40
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
17
17
17
N
2
-5.86
0.60
121.00
115.14
A
A
A
CB
CG
CD2
TYR
TYR
TYR
29
29
29
N
2
-13.80
2.20
111.40
97.60
A
A
A
CG1
CB
CG2
ILE
ILE
ILE
33
33
33
N
2
-4.30
0.60
121.00
116.70
A
A
A
CB
CG
CD1
TYR
TYR
TYR
44
44
44
N
3
-5.23
0.70
120.80
115.57
A
A
A
CB
CG
CD2
PHE
PHE
PHE
13
13
13
N
3
-6.85
0.60
121.00
114.15
A
A
A
CB
CG
CD2
TYR
TYR
TYR
29
29
29
N
3
-5.71
0.60
121.00
115.29
A
A
A
CB
CG
CD1
TYR
TYR
TYR
44
44
44
N
4
-5.40
0.70
120.80
115.40
A
A
A
CB
CG
CD2
PHE
PHE
PHE
13
13
13
N
4
3.98
0.50
120.30
124.28
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
17
17
17
N
4
-5.31
0.60
121.00
115.69
A
A
A
CB
CG
CD2
TYR
TYR
TYR
29
29
29
N
4
-5.60
0.60
121.00
115.40
A
A
A
CB
CG
CD1
TYR
TYR
TYR
44
44
44
N
5
-5.52
0.70
120.80
115.28
A
A
A
CB
CG
CD2
PHE
PHE
PHE
13
13
13
N
5
-3.75
0.60
121.00
117.25
A
A
A
CB
CG
CD1
TYR
TYR
TYR
29
29
29
N
5
-5.11
0.60
121.00
115.89
A
A
A
CB
CG
CD1
TYR
TYR
TYR
44
44
44
N
6
3.08
0.50
120.30
123.38
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
17
17
17
N
6
-3.85
0.60
121.00
117.15
A
A
A
CB
CG
CD1
TYR
TYR
TYR
29
29
29
N
7
-5.91
0.70
120.80
114.89
A
A
A
CB
CG
CD2
PHE
PHE
PHE
13
13
13
N
7
-6.02
0.60
121.00
114.98
A
A
A
CB
CG
CD2
TYR
TYR
TYR
29
29
29
N
7
-5.86
0.60
121.00
115.14
A
A
A
CB
CG
CD1
TYR
TYR
TYR
44
44
44
N
8
-4.83
0.70
120.80
115.97
A
A
A
CB
CG
CD2
PHE
PHE
PHE
13
13
13
N
8
-5.22
0.60
121.00
115.78
A
A
A
CB
CG
CD2
TYR
TYR
TYR
29
29
29
N
8
-5.32
0.60
121.00
115.68
A
A
A
CB
CG
CD1
TYR
TYR
TYR
44
44
44
N
1
A
THR
21
-8.51
-71.71
1
A
PRO
36
-38.71
-38.51
2
A
SER
6
-108.67
41.34
2
A
ILE
7
47.84
-41.24
2
A
THR
21
-148.78
-68.39
2
A
ALA
38
73.50
-0.64
3
A
THR
30
-143.50
50.10
3
A
ALA
38
111.41
-16.49
3
A
ALA
45
-103.75
43.70
4
A
THR
2
-101.55
60.09
4
A
THR
21
-147.14
-71.30
4
A
ALA
45
-108.56
78.43
5
A
THR
2
-110.85
73.66
5
A
THR
21
-61.14
-70.39
5
A
ALA
45
-95.21
50.40
6
A
THR
2
-101.87
60.19
6
A
THR
21
-149.47
-67.52
7
A
ARG
17
-97.07
40.71
7
A
PRO
19
0.24
-65.88
8
A
THR
2
-102.51
68.66
8
A
THR
21
-154.55
-69.28
8
A
THR
30
-145.19
49.12
8
A
ALA
38
48.21
-29.13
8
A
ALA
45
-91.07
35.75
CRAMBIN (PRO 22/LEU 25) (NMR, 8 STRUCTURES)
DIRECT NOE REFINEMENT OF CRAMBIN FROM 2D NMR DATA USING A SLOW-COOLING ANNEALING PROTOCOL
1
Y
N
A
ILE
7
A
ILE
7
HELX_P
3/10 CONFORMATION RES 17,18
A
LEU
18
A
LEU
18
1
H1
12
A
GLU
23
A
GLU
23
HELX_P
A
THR
30
A
THR
30
1
H2
8
disulf
2.033
A
CYS
3
A
SG
CYS
3
1_555
A
CYS
40
A
SG
CYS
40
1_555
disulf
2.038
A
CYS
4
A
SG
CYS
4
1_555
A
CYS
32
A
SG
CYS
32
1_555
disulf
2.049
A
CYS
16
A
SG
CYS
16
1_555
A
CYS
26
A
SG
CYS
26
1_555
PLANT SEED PROTEIN
PLANT SEED PROTEIN
CRAM_CRAAB
UNP
1
1
P01542
TTCCPSIVARSNFNVCRLPGTPEALCATYTGCIIIPGATCPGDYAN
1
46
1CCM
1
46
P01542
A
1
1
46
2
anti-parallel
A
THR
1
A
THR
1
A
CYS
4
A
CYS
4
A
CYS
32
A
CYS
32
A
ILE
35
A
ILE
35
1
P 1